Evaluation of Serum Ages Levels in Patients With Endometriosis

Kanuni Sultan Suleyman Training and Research Hospital

Status: Completed

Conditions: Endometriosis

Treatments: Other: Advanced Glycation End Products (AGEs)

Study type: Observational

Funder types: Other

Identifiers

NCT04886024

endo-serum ages levels

Details and patient eligibility

About

Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Full description

Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.

Enrollment: 90 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• diagnosed with endometriosis (Surgery or ultrasound)
• Women without endometriosis

Exclusion criteria

• Women without endometriosis women who are only suspected endometriosis

Trial design

90 participants in 2 patient groups

women with endometriosis

Description:

It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography.

Treatment:

Other: Advanced Glycation End Products (AGEs)

control

Description:

It consists of healthy women between the ages of 18-45

Treatment:

Other: Advanced Glycation End Products (AGEs)